Ligand-driven dimerizations of ErbB receptor subunits fulfill a fundamental role in their activation. We have used the number and brightness analysis technique to investigate the existence of preformed ligand-independent dimers and clusters and to characterize the initial steps in the activation of ErbB1 and ErbB2. In cells expressing 50,000-200,000 receptors, ErbB1 was monomeric in the absence of ligand stimulation, whereas in CHO cells with receptor levels >500,000 as much as 30% of ErbB1 was present as preformed dimers. EGF induced the formation of ErbB1 dimers as well as larger clusters (up to pentamers) that colocalized with clathrin-coated pits. The distribution of unstimulated ErbB2 in cells expressing 3·10 5 − 10 6 receptors was fundamentally different, in that this receptor was present in preformed homoassociated aggregates containing 5-10 molecules. These constitutive ErbB2 homoclusters colocalized with caveolae, increased in size at subphysiological temperatures, but decreased in size upon EGF stimulation. We conclude that these ErbB2 clusters are promoted primarily by membrane-mediated interactions and are dispersed upon ligand stimulation.
Ligand-driven dimerizations of ErbB receptor subunits fulfill a fundamental role in their activation. We have used the number and brightness analysis technique to investigate the existence of preformed ligand-independent dimers and clusters and to characterize the initial steps in the activation of ErbB1 and ErbB2. In cells expressing 50,000-200,000 receptors, ErbB1 was monomeric in the absence of ligand stimulation, whereas in CHO cells with receptor levels >500,000 as much as 30% of ErbB1 was present as preformed dimers. EGF induced the formation of ErbB1 dimers as well as larger clusters (up to pentamers) that colocalized with clathrin-coated pits. The distribution of unstimulated ErbB2 in cells expressing 3·10 5 − 10 6 receptors was fundamentally different, in that this receptor was present in preformed homoassociated aggregates containing 5-10 molecules. These constitutive ErbB2 homoclusters colocalized with caveolae, increased in size at subphysiological temperatures, but decreased in size upon EGF stimulation. We conclude that these ErbB2 clusters are promoted primarily by membrane-mediated interactions and are dispersed upon ligand stimulation.
EGFR | epidermal growth factor | ErbB proteins | receptor clusters | signal transduction E rbB proteins (ErbB1-4, HER1-4) constitute the best characterized family of receptor tyrosine kinases (1) . Biochemical analysis has demonstrated that ErbB1, the prototypical member of the family (also known as the epidermal growth factor receptor, EGFR or HER1) undergoes ligand-induced homodimerization as a key step in its activation (2) . More recent crystallographic studies reveal that ligand binding induces a transition from a closed conformation of ErbB1 to an extended configuration with the capacity to dimerize via intermolecular interactions mediated by domain II (3, 4) . The ultrastructural data also confirm that dimerization of ErbB1 plays a fundamental role in activating the kinase domain by a mechanism resembling that of cyclin dependent kinases (5, 6) . The coreceptor ErbB2 has no known ligand but upon transactivation expresses the most potent kinase activity of the ErbB family, thereby increasing the efficiency of signaling mediated by ErbB2-containing heterodimers (7) . ErbB2 constitutively adopts an extended conformation potentiating the formation of heterodimers (8, 9 ) that can be inhibited by pertuzumab, a monoclonal antibody sterically blocking the heterodimerization arm of ErbB2 (10) . Although the extracellular domain of ErbB2 has failed to form crystallographic homodimers, molecular biological and fluorescence resonance energy transfer (FRET) experiments have shown that full-length ErbB2 exists in dimers or higher-order aggregates in the plasma membrane (11, 12) . The implication is that the transmembrane, juxtamembrane and other intracellular domains (5, 13, 14) act in conjunction with the membrane environment (15) to mediate the dimerization and, thereby, functional states of ErbB proteins.
Many investigators have sought to determine the distribution of ErbB1 in the plasma membrane in an attempt to explain the molecular basis for the apparent high-and low-affinity ligand binding. The findings suggest the existence of preformed (i.e., ligand-independent, ErbB1 receptor dimers) (16, 17) or larger aggregates (18) in addition to the classical dimers formed upon ligand-induced activation of receptor monomers. However, the different techniques, cell types, and conditions of the experiments have resulted in conflicting and contradictory results. Several studies using fixed cells and/or low temperature incubations based on hetero-or homo-FRET have indicated that <10% to as much as 50% of ErbB1 may exist as preformed dimers or oligomers (17, 19, 20) . Inhibition of the tyrosine kinase activity of the receptor led to disaggregation of the transient dimers and clusters to monomers (18) , suggesting that some measurements may have been made on nonstarved cells with preactivated receptors. On the other hand, fluorescence correlation spectroscopy (FCS) measurements on living, starved cells were consistent with earlier evidence for low levels of preformed dimers and very few oligomers (21) . Recently, flow cytometric homo-FRET data demonstrated that homoclustering of ErbB2 was significantly stronger than ErbB1 and that homoaggregates of ErbB2, containing inactive proteins, were recruited into ErbB1-or ErbB3 containing heterodimers upon ligand binding (22) .
We have utilized a new correlation method introduced by the Gratton lab (23) that directly assesses the molecular size of diffusing macromolecules in living cells by number and brightness (N&B) determinations based on the analysis of sequential confocal microscopy images acquired by calibrated single photon detection. The fluctuation of fluorescence intensities in single pixels provides a measure of molecular brightness (i.e., the number of detected photons emitted by a single diffusing unit of a given fluorescent species during the pixel dwell time). We found that ErbB1 is monomeric at low expression levels, but forms ligand-independent dimers in an expression-level and cell-type dependent manner. Binding of EGF induces a practically complete dimerization of ErbB1, with higher-order clusters primarily associated with clathrin-coated pits. On the contrary, ErbB2 forms homoclusters containing 5-10 proteins in the absence of stimulation, and these clusters are reduced in size after stimulation by EGF. In the absence of ligand the ErbB2 clusters increase in size at subphysiological temperatures. Our results resolve many of the published contradictions regarding the existence of pre- Freely available online through the PNAS open access option. 1 To whom correspondence should be addressed. E-mail: djovin@gwdg.de. formed ErbB clusters and their rearrangement after ligand stimulation and show that expression levels as well as temperaturedependent membrane rearrangements lead to significantly different receptor distributions.
Results
Preassociated ErbB1 Is Induced to Dimerize in Cells Expressing the Receptor at a High Level. The F1-4 line (transfected CHO cells stably expressing ∼600;000 ErbB1-eGFP/cell (24) was used as a model system for cells overexpressing the ErbB1 receptor. Clustering of ErbB1 in starved cells was measured using the N&B approach. The distribution of brightness values was homogeneous indicating that clustering of ErbB1 did not show a steep dependence on the local density of the protein within the limited concentration range sampled on a single cell (Figs. 1A and 2A) . The molecular brightness values of ErbB1-eGFP were ∼30% higher than those of monomeric eGFP implying that a fraction of ErbB1 was present in preformed receptor clusters ( Table 1 ). The existence of preformed receptor dimers in F1-4 cells was confirmed by photobleaching ∼80% of the fluorescence after which the molecular brightness of ErbB1-eGFP approximated that of soluble, monomeric eGFP (Fig. 1B and Table 1 ). Stimulation of F1-4 cells by 100 nM EGF for 3 min at room temperature increased the cluster size of ErbB1 significantly (Figs. 1A and 2B) to a value that was ∼80% higher than monomeric eGFP ( Table 1 ). The brightness histogram shifted homogenously to higher values upon EGF treatment (Fig. 1A ), but the dependence of the brightness on the fluorescence intensity was weak ( Fig. 2B and Fig. S1E ). These observations indicate that the growth factor induced an almost complete dimerization of the receptor population.
Preformed Clusters of ErbB1 Are Absent in Cells Expressing the Receptor at Low Levels. The observation of preformed ErbB1 clusters in unstimulated F1-4 cells might not represent the behavior of the receptor under physiological conditions due to the high overexpression in these cells. We investigated two other model systems with significantly lower levels of ErbB1 expression. F1-10 is another transfected CHO line stably expressing ∼50;000 ErbB1-eGFP/cell (25) , whereas the human HeLa-ErbB1eGFP line expresses ∼200;000 ErbB1-eGFP/cell in a background of 50,000 endogenous, unlabeled ErbB1 receptors. The molecular brightness of ErbB1-eGFP measured in starved F1-10 and HeLaErbB1eGFP cells was only 3-5% higher than that of monomeric eGFP, indicating that the majority of ErbB1-eGFP was monomeric in unstimulated cells expressing moderate to low levels of the receptor (Fig. 1C, Fig. S1C , and Table 1 ). The brightness of ErbB1-eGFP showed a steeper dependence on its local density in F1-10 than in F1-4 cells ( Fig. 2 A and C) . Stimulation of both F1-10 and HeLa-ErbB1eGFP cells led to significant increases in the molecular brightness of ErbB1-eGFP (Table 1) , and the distribution in EGF-stimulated F1-10 cells deviated significantly from a unimodal Gaussian (Fig. 1C ), correlating strongly with the local density (mean fluorescence intensity) of ErbB1-eGFP (Fig. 2C ). Larger clusters of the receptor induced by EGF ( Fig. 2D and Fig. S1 F and G) were colocalized with clathrin-coated pits after fixation and immunfluorescence labeling (S1H and Figs. S2A). Such clusters were not observed in either quiescent or stimulated F1-4 cells ( Fig. S1 A and B). Three overlapping Gaussians were required to fit the brightness distribution of EGF-stimulated F1-10 cells (Fig. 1D ), rightmost peak corresponding to ∼5 ErbB1-eGFP in clathrin-coated pits.
The Propensity of ErbB2 to Form Homoclusters Is Greater than that of ErbB1. Starved A4erbB2 cells (26) expressing ∼1.2·10 6 and 10 6 endogenous ErbB1 and ErbB2-mYFP, respectively, showed remarkably heterogeneous clustering of ErbB2 both at the microscopic and molecular levels. Conspicuous "macroclusters" of ErbB2 were observed in microscopic images (Fig. S3) . The molecular brightness of ErbB2-mYFP was significantly higher in these macroclusters than outside them (Figs. 3 A and C and 4 A-D), but the N&B analysis demonstrated that ErbB2 was homoassociated in both locations (Table 1) . A similar tendency was observed in CHO cells stably expressing ∼300;000 ErbB2/cell but lacking the other ErbB proteins. However, in this cell line the size of molecular homoclusters of ErbB2 was even larger (Table 1) , averaging 5-15 inside and 3-4 ErbB2 molecules outside the macroclusters. ErbB2-mYFP in the central and most intense part of the macroclusters had a lower molecular brightness than at the periphery ( Fig. S3A and Fig. 4B ). We attribute this observation to a lower mobility of ErbB2 in the central and most dense part of the clusters.
Temperature changes are expected to affect the clustering properties of integral membrane proteins that associate with specific lipid environments (15, 27, 28) . Macroclusters of ErbB2 gradually increased in size and density after transferring cells from 37°C to room temperature over a period of 2 h (Fig. S3) .
Several factors might contribute to increased homoaggregation of ErbB2 compared with ErbB1: (i) the C-terminal PDZ binding motif that interacts with intracellular proteins such as Erbin and Pick1 (29); (ii) linker regions to the mYFP moiety (26); or (iii) the mYFP moiety itself (30) . Additional transgenes were constructed: ErbB2-short-mYFP, with a dipeptide linker; ACP-ErbB2, an amino terminal acyl carrier protein (ACP) sequence insertion (31); and C-terminal VPV deletion mutants of both constructs. N&B measurements on transiently transfected HeLa cells expressing ErbB2-short-mYFP yielded data identical to those observed with the original ErbB2-mYFP vector (Fig. S4A and Table S1 ). Enzymatic covalent labeling of the ACP-ErbB2 in the plasma membrane of transfected HeLa cells with Atto-565-CoA displayed identical clustering properties to mYFP-labeled ErbB2 (Fig. S4B and Table S1 ). Finally, the cluster sizes of wild-type ErbB2 and ΔVPV-ErbB2 were not significantly different from each other in cells transfected with either mYFP-tagged or ACP-conjugated versions of the vectors (Fig. S4 A and B and Table S1 ). Colocalization experiments with immunolabeling are described in SI Text and confirmed that no fluorescence signal contributions from internal vesicles or binding to extracellular matrix contributed to the molecular brightness determinations while macroclusters colocalize with caveolin (Fig. S5 ). Table 1 ). Ligand-activated ErbB1 recruited ErbB2 from homoclusters into ErbB1-2 heterodimers. Pertuzumab, an antibody blocking the heterodimerization of ErbB2, decreased the molecular brightness values of ErbB2-mYFP in starved cells and abolished the decrease induced by EGF (Table 1) . We conclude that the observed EGF-induced decrease in the size of molecular homoclusters of ErbB2 was the consequence of the recruitment of ErbB2 into heterodimers by ligand-activated ErbB1.
ErbB2 Is Removed from Preformed
Homoclusters upon EGF Stimulation. A4erbB2 cells were used to measure the effect of EGF stimulation on the molecular clustering of ErbB2. EGF significantly decreased the size of molecular clusters of ErbB2 inside macroclusters without affecting external molecules (Fig. 3 B and C and
Discussion
According to the widely accepted molecular scheme underlying the biology of ErbB receptor tyrosine kinases, inactive monomeric receptors undergo ligand-induced dimerization and activation (32) . Although several lines of evidence (3, 4) , support this view, both recent and earlier evidence (16) (17) (18) (20) (21) (22) have suggested that two aspects of the classical model need to be reconsidered: (i) inactive receptors are not necessarily monomeric, such that (ii) higher-order clusters of inactive and/or activated receptors may exist. We chose the novel technique of N&B analysis (23) to investigate these issues. Clusters detected by N&B analysis are defined in terms of joint mobility, whereas FRET measurements resolve aggregates based on proximity. The underlying principles of N&B and FCS measurements are the same and both measure the distribution and association states of molecules in live cells. N&B data are statistically more reliable due to the larger number of pixels used in the analysis compared with FCS. Fluorescence intensity distribution analysis and photon count histogram analysis have the potential to yield information on the distribution of cluster sizes within single pixels, something that cannot be achieved by N&B analysis. However, their requirement for highly accurate photon statistics necessitates high illumination intensities leading to photodamage (21) .
The molecular brightness value of ErbB1-eGFP in unstimulated F1-4 cells expressing the receptor at a high level (>500;000∕ cell) was higher than that of monomeric eGFP and approached a value characteristic of preformed dimers in pixels with the highest local density. The brightness value indicated the presence of ∼30% preformed dimers with no indication of higher oligomers, in agreement with previous FCS results (21) . In contrast, unstimulated ErbB1 was monomeric in two different cell lines (F1-10, HeLaErbB1eGFP) expressing the receptor at a lower level (50;000-200;000∕cell) found on primary, nononcogenic cells. These observations suggest that the existence of preformed ErbB1 dimers is strongly dependent on the expression level and density of the receptor, and thus, may reflect the establishment of thermodynamic equilibrium. There may also be a contribution of lipid rafts and gangliosides to the tendency of ErbB1 to form preformed dimers (15, 33, 34) . The fact that CHO cells do not express GM1 should also be taken into consideration (35) .
Stimulation of cells with EGF led to an increase in the cluster size of ErbB1. In the high-expression F1-4 cell line the brightness histogram shifted homogeneously to larger values after EGF stimulation and the mean value of the unimodal distribution was ∼1.8-times that of monomeric eGFP, demonstrating an almost complete dimerization of ErbB1 upon EGF treatment. F1-10 cells expressing ErbB1 at a much lower level (∼1∕10) behaved differently. The EGF-induced increase in the average molecular brightness was lower and the brightness histogram was unsymmetrical. Decomposition of the brightness histogram revealed that the main peak and the brightest subpopulation corresponded to monomeric and pentameric ErbB1, respectively. After fixation pentameric clusters could be colocalized with clathrin-coated pits by antibody labeling. We conclude that EGF-stimulation led to activation and dimerization of ErbB1 followed by immediate recruitment to clathrin-coated pits, leaving behind the remaining inactive and monomeric receptors. In F1-4 cells with high ErbB1-eGFP expression there was rapid recruitment of almost all the ErbB1 molecules into activated dimers after addition of EGF, masking the rather low number of clathrin-coated pits that were presumably saturated (36) .
Whereas biochemical data (37) and X-ray crystallography (3, 4) suggest that inactive ErbB1 is monomeric, hetero-FRET (16) (17) (18) , homo-FRET (19, 22, 38) , and FCS (20, 21, 25) measurements have found evidence for dimers, or in a few cases for higher-order clusters. We propose that several cell-and measurement-dependent factors contribute to the discrepancies in the literature: (i) the strong dependence of preformed ErbB1 dimers on expression levels established in this study accounts for the presence of preformed clusters in cells (e.g., A431) with high receptor densities (16, 17) ; (ii) fixation and labeling by bivalent antibodies may artificially generate receptor aggregates (39); and (iii) the continuous cycle of phosphorylation and dephosphorylation of ErbB1 induced by autocrine stimulation or lack of starvation. ErbB1 is fully inactivated only in serum-deprived cells (40) , and some protocols have even used phosphatase inhibitors (41), a situation promoting the formation of activated dimers. Thus, the observation of ErbB1 clusters persisting in nonstarved cells (20) leads to the erroneous conclusion that they preexist in unstimulated cells.
The perception of clusters, extending from dimers to aggregates containing hundreds of proteins (22, 42) , may also reflect the size-dependent selectivity of the methods used to investigate them. Dimers observed by X-ray crystallography are direct associations on the molecular level, whereas positive FRET signals imply molecular proximity but not necessarily specific molecular interactions. Furthermore, hetero-FRET cannot discriminate between small and large aggregates, because cluster size only slightly affects the transfer efficiency (43), whereas homo-FRET is more suitable for the detection of higher-order associations (22, 38, 44) . In addition, methods based on the measurement of fluorescence correlations, including N&B analysis, detect joint mobility, which can arise not only from tight molecular associations, but also by mutual confinement by membrane structures (45) . The use of image correlation techniques [image correlation spectroscopy or dynamic image correlation spectroscopy (DICS)] (27, 46) to determine molecular associations applied to fixed cells is much less reliable due to fixation artifacts, photon statistics, and the optical resolution of the microscope. The overestimation of clustering or aggregate formation by DICS is apparent even in live cells from the calculated diffusion constant of 2.5·10 −11 cm 2 ∕s for ErbB1 (27) , compared to values greater by one to two orders of magnitude obtained by fluorescence recovery after photobleaching (47, 48) , FCS (21, 25), and single particle tracking (49) .
We propose the following model for the ErbB1 receptor, one which is in agreement with most experimental results.
• Inactive ErbB1 is monomeric when expressed at physiological, nononcogenic levels.
• Density-dependent formation of preformed clusters occurs in cells expressing the receptor at high levels. Molecules in these preformed clusters can be held together by two different types of interactions: (i) Mutual confinement by membrane-or cytoskeleton-mediated indirect interactions. Because lipid rafts harbor ErbB1 and influence its association state they are likely candidates for exerting the membrane-mediated confinement of ErbB1 (34, 50) . The existence of preformed dimers stabilized by indirect interactions is supported by the observation of such transient protein clusters in which the distance between proteins is larger than the range of direct molecular interactions. Therefore, these clusters do not constitute stable molecular associations such as those arising after ligand binding (45) .
(ii) Direct protein-protein interactions mediated by the dimerization arm of ErbB1. It has recently been demonstrated that preformed ErbB1 dimers stabilized by their dimerization arms can arise transiently (51) but these are highly dependent upon receptor density.
ErbB2 showed a behavior strikingly different from ErbB1. In the absence of stimulation the receptors were present in preformed clusters. Microclusters of 5-15 ErbB2 receptors were found associated in larger macroclusters of ∼1 μm (probably also composed of other proteins as shown in the supplementary data). Outside of these macroclusters 3-5 ErbB2 molecules were homoassociated and little monomeric protein was observed. The size of ErbB2 homoclusters was significantly larger in cells in which ErbB2 was expressed as the only member of the ErbB family (CHO-ErbB2mYFP) compared to A4erbB2 cells that coexpress ∼1.2·10 6 ErbB1 with 10 6 ErbB2-mYFP. We assume that the more extensive formation of ErbB2 homoclusters in CHO-ErbB2- mYFP cells was due to the absence of other competing ErbB proteins. This interpretation is supported by earlier near field optical microscopy data that demonstrated larger ErbB2 clusters in a CHO cell line expressing less than 10 5 receptors/cell compared with the cluster size in MDA453 cells expressing ErbB2, ErbB3, and ErbB4, each at levels of ∼10 5 (42) . Macroclusters of ErbB2 colocalized with caveolin and ErbB1, a finding in accordance with the presumed raft-association of ErbB2 (15) and the colocalization of ErbB1 with caveolin in resting cells (50) . EGF led to a decrease in the homoaggregation state of ErbB2 within macroclusters by recruitment and heterodimerization without significantly affecting the bulk of the ErbB2, in agreement with previous homo-FRET data (22) . In polarized epithelial cells ErbB2 is targeted to the basolateral membrane by PDZ domain-containing proteins such as Erbin and may be clustered at specific sites by interaction with PICK1 (29) . We eliminated the C-terminal PDZ binding sequence as well as a valine and proline-rich cloning linker to the mYFP tag with VPV deletion mutants and ACP-ErbB2 constructs. No changes in the cluster size or frequency were detected in these constructs compared with wild-type ErbB2. In addition to the PDZ binding motif several other domains of ErbB2 have been reported to contribute to its peculiar association properties, including the transmembrane domain (13) and the sequence 966-968 in the intracellular domain (52) . Although not explicitly shown to be important for the homoassociation of ErbB2 the juxtamembrane domain (53) and the kinase domain (6) of ErbB1 are known to regulate dimerization; therefore the role these regions in inducing ErbB2 homocluster formation cannot be excluded. In addition, interactions of the extracellular glycosolation chains and the EGF-like domain of the membrane-bound mucin Muc-4 (54) could also promote ErbB2 homoaggregation.
We observed a time-dependent growth of ErbB2 macroclusters after a temperature shift from 37 to 20°C. Such thermally induced increase in the clustering of ErbB1 (27) and other proteins (28) has been reported previously. The finding of temperaturedependent cluster formation of ErbB2 is in accordance with the observation of lipid phase separation in plasma membrane vesicles in the temperature range of 15-25°C (55) and the raft association of ErbB2 (15) . Because incubation at nonphysiogical temperatures can drastically alter the natural state of receptor distribution, conclusions regarding clustering of membrane proteins derived from data obtained in experiments involving long-term incubation at room temperature or even short-term incubation on ice should be treated with great caution.
In conclusion, we have shown that although inactive ErbB1 molecules dimerize in a density-dependent manner, these associations are not equivalent to the stable molecular dimers that form after ligand stimulation. ErbB2 has a much stronger propensity for homocluster formation, but is recruited away from these homoaggregates after EGF stimulation and formation of heteroassociations. Our results provide significant insights into the underlying molecular processes taking place during the initial steps of ErbB protein activation. Two-color N&B experiments (56) will reveal the composition of heteroclusters and provide unique insights into the mechanisms of potentiated signaling in cells expressing different sets of ErbB family members.
Materials and Methods
Cell Lines. All cell lines have been described previously (24) (25) (26) 38) . Characterization of the expression levels are detailed in SI Materials and Methods. For microscopy experiments cells were cultured in 2-or 8-well coverglass chambers (Nalgene Nunc International) and stimulated with 100 nM EGF (R&D Systems) at room temperature.
Plasmids. Protocols for generating the ACP-ΔVPV-ErbB2, ErbB2-short-mYFP, and ΔVPV-ErbB2-short-mYFP are given in SI Materials and Methods.
Antibodies, Cell Labeling, and Fluorescence Microscopy for Colocalization. Information about the antibodies and experimental conditions for the data shown in Fig. S5 are given in SI Materials and Methods.
Number and Brightness Analysis. An IX81 Olympus microscope with the FluoView FV1000 confocal configuration was used to carry out number and brightness analysis according to Digman et al. (23) . Live cells were analyzed at room temperature in Tyrode's buffer with 10 mM glucose and 0.1% BSA. Measurements were started immediately after removing cells from 37°C and finished within 30 min to avoid changes in the distribution of receptors at room temperature. Image series of 50-100 single optical slices of the cell membrane adjacent to the coverslip were acquired in the pseudophoton counting mode with a pixel size of 41 nm at laser powers of 70 μW of 488 nm for eGFP, 90 μW of 514 nm for mYFP and 130 μW of 543 nm for Atto565-labeled samples. See SI Text for additional details concerning imaging and analysis methods.
